Meta-Analyses of the Association Between Cytochrome CYP2C19 Loss- and Gain-of-Function Polymorphisms and Cardiovascular Outcomes in Patients With Coronary Artery Disease Treated With Clopidogrel

Study Questions:

What is the association between CYP2C19 loss- and gain-of-function variants and cardiovascular outcomes and bleeding in patients with coronary artery disease treated with clopidogrel?